Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market.We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 14, 2022 | Series D | — | 1 | — | — | Detail |
Jan 22, 2021 | Series C | $86K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Longda Foods | — | Series D |
TPG | — | Series C |